Skip to content

4D Molecular Therapeutics, Inc.

FDMT· NasdaqCore metricsCIK 1650648

Biological products, except diagnostic substances175 peers

Last sale
Nov 12, 2026 · -6.78%
Market cap
$682.13M
56.37M shares
Filings
444
$4.15M
Q3 2026+230,194.6% FY25 yoy
-$78.06M
Q3 2026N/M FY25 yoy
-$81.22M
Q3 2026N/M FY25 yoy
-$194.94M
Q3 2026derivedN/M FY25 yoy
-$1.08
Q3 2026N/M FY25 yoy
$39.10M
Q3 2026−59.7% FY25 yoy
$682.13M
—
7.1×
2.0×
—
—

Twelve months to Sep 30, 2026 · derived

Price

$12.10+12.04%+$1.30past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$85.21MFY 2025
$85.21M0FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$85,209,000reported
FY 20242024-12-31$37,000reported
FY 20232023-12-31$20,723,000reported
FY 20222022-12-31$3,129,000reported
FY 20212021-12-31$18,038,000reported
FY 20202020-12-31$13,363,000reported
FY 20192019-12-31$6,960,000reported

Segments

Geography
Revenue by Geography, FY2019 to FY2025FY2019United States · FY2019 · $666.00KAustralia · FY2019 · $7.00KNetherlands · FY2019 · $26.00KSwitzerland · FY2019 · $6.29MFY2020Netherlands · FY2020 · $742.00KSwitzerland · FY2020 · $12.90MFY2021United States · FY2021 · $121.00KNetherlands · FY2021 · $736.00KSwitzerland · FY2021 · $17.18MFY2022United States · FY2022 · $35.00KNetherlands · FY2022 · $3.09MFY2023United States · FY2023 · $20.16MNetherlands · FY2023 · $567.00KFY2024United States · FY2024 · $37.00KFY2025Japan · FY2025 · $85.00MUnited States · FY2025 · $209.00K
LineFY2025ShareChange
Japan$85.00M100%—
United States$209.00K0.2%+464.9%
Australia———
Netherlands———
Switzerland———
Total$85.21M

From the 10-K filed Mar 18, 2026FDMT

Biological products, except diagnostic substances

4D Molecular Therapeutics, Inc. is the 32nd largest of the 176 covered companies the SEC files under this code, by revenue. SIC 2836

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

4D Molecular Therapeutics, Inc. · CIK 1650648 · Engraved from SEC EDGAR